Adicet Bio
$11.379876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.10 (+0.89%) As of 1:40 PM EDT today
Why Robinhood?
You can buy or sell Adicet Bio and other stocks, options, and ETFs commission-free!
About ACET
Adicet Bio, Inc. Common Stock, also called Adicet Bio, is a biotechnology company which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Read More The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA. The listed name for ACET is Adicet Bio, Inc. Common Stock.
CEO
Chen Schor
Employees
18
Headquarters
Boston, Massachusetts
Founded
2014
Market Cap
222.74M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
48.03K
High Today
$12.12
Low Today
$11.06
Open Price
$11.31
Volume
9.40K
52 Week High
$21.40
52 Week Low
$0.86
Collections
ACET Earnings
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, Pre-Market